GEODE CAPITAL MANAGEMENT, LLC
Holdings History for NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY)
- Symbol
- NBY on NYSE
- Investment type
- Equity / Common Stock, $0.01 par value
Shares, Excluding Options vs Price
Value, Excluding Options
| Holdings date | Option | Weight | Change | Value $ | Shares | Change | Activity % | Price | All Holders |
|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 2025 | 0% | +0% | $7,097,514 | 1,257,705 | +1,205,984 | +2332% | $5.64 | Q4 2025 | |
| 30 Sep 2025 | 0% | +0% | $66,202 | 51,721 | +17,898 | +53% | $1.28 | Q3 2025 | |
| 30 Jun 2025 | 0% | 0% | $19,617 | 33,823 | -1,173 | -3.4% | $0.58 | Q2 2025 | |
| 31 Mar 2025 | 0% | 0% | $20,472 | 34,996 | +1,966 | $0.58 | Q1 2025 | ||
| 31 Dec 2024 | 0% | 0% | $19,850 | 33,030 | +6,693 | +25% | $0.60 | Q4 2024 | |
| 30 Sep 2024 | 0% | +0% | $18,148 | 26,337 | +26,337 | NEW | $0.69 | Q3 2024 |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.